| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/14/2009 | US20090123416 Methods for the treatment of bladder cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 05/14/2009 | US20090123401 Method of Predicting Spot Formation on the Skin Using Spot Site-Accelerating Genes as an Indicator Thereof and Method of Screening Inhibitors of Spot Formation on the Skin |
| 05/14/2009 | US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/14/2009 | CA2705097A1 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 05/14/2009 | CA2705014A1 Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
| 05/14/2009 | CA2704663A1 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058009A1 Reverse targeting lipid vesicle |
| 05/13/2009 | EP2058008A1 Anti-obesity agent and use thereof |
| 05/13/2009 | EP2057997A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 05/13/2009 | EP2056876A1 Biomarkers for alzheimer's disease progression |
| 05/13/2009 | EP2056875A1 Novel compositions and methods |
| 05/13/2009 | EP2056861A2 Vaccine immunotherapy |
| 05/13/2009 | EP2056838A2 Combination therapy for treatment of immune disorders |
| 05/13/2009 | EP2056831A2 Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases |
| 05/13/2009 | EP2056829A2 Using pi3k and mek modulators in treatments of cancer |
| 05/13/2009 | EP2056819A2 Cholesterol lowering drug combination |
| 05/13/2009 | EP2056814A1 2,5-dihydroxybenzene compounds for the treatment of psoriasis |
| 05/13/2009 | EP2056813A1 2,5 dihydroxybenzene compounds for the treatment of rosacea |
| 05/13/2009 | EP2056807A2 Treatment of inflammatory diseases |
| 05/13/2009 | EP2056800A2 Therapy procedure for drug delivery for trigeminal pain |
| 05/13/2009 | EP2056799A2 Compositions and methods for treating or preventing glaucoma or progression thereof |
| 05/13/2009 | EP2056791A2 Pharmaceutical compositions including vitamin d and corticosteroid |
| 05/13/2009 | EP1490490B1 Antisense iap nucleobase oligomers and uses thereof |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1327440B1 Oral preparations with favorable disintegration characteristics |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1299104B1 Tamper-resistant oral opioid agonist formulations |
| 05/13/2009 | EP1220617B1 Fish feed with increased nucleotide content |
| 05/13/2009 | EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 05/13/2009 | EP0914325B1 Modulators of the function of fas receptors and other proteins |
| 05/13/2009 | CN101432024A Use of organic compounds |
| 05/13/2009 | CN101428006A Microparticle compositions and methods for the manufacture thereof |
| 05/13/2009 | CN101427994A Gemcitabine-containing anti-cancer medicine sustained-release injection |
| 05/13/2009 | CN100486643C Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability |
| 05/13/2009 | CN100486589C Slow release antibiotics preparation of bioactive substance |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486560C Slow released compound anticancer injection containing blood vessel inhibitor |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531567 effector ambroxole with ACE inhibitors; treatment of a disturbance of the thiol-disulfide status in kidney replacement therapy |
| 05/12/2009 | US7531562 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531511 Injecting fibroblast growth factor-2 directly into the myocardium |
| 05/12/2009 | US7531510 Methods of recruiting fibroblasts by administering G-CSF |
| 05/12/2009 | US7531501 Method of treating endothelial injury |
| 05/12/2009 | US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine |
| 05/12/2009 | US7531358 Method of quantifying surfactant |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531191 Stimuli-responsive systems for controlled drug delivery |
| 05/12/2009 | US7531181 Gp120 specific antigens and uses thereof |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
| 05/12/2009 | CA2387398C Novel combination of loteprednol and antihistamines |
| 05/12/2009 | CA2335353C Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/12/2009 | CA2315829C Angiostatic agents and compositions for controlling ocular hypertension |
| 05/12/2009 | CA2228266C Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 05/07/2009 | WO2009058005A2 Unit dosage for brain health |
| 05/07/2009 | WO2009057994A1 Unit dosage for brain health |
| 05/07/2009 | WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein |
| 05/07/2009 | WO2009056232A2 Combination of pde5 inhibitors with muscarinic receptor antagonists |
| 05/07/2009 | WO2009056146A1 Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat |
| 05/07/2009 | WO2009055934A1 Treatment of fibrillinopathy or elastinopathy using granzyme inhibitors |
| 05/07/2009 | WO2009032172A3 Platinum compositions as treatment for oct-related cancers |
| 05/07/2009 | WO2009017701A3 Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment |
| 05/07/2009 | WO2009012357A3 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof |
| 05/07/2009 | WO2008127682A3 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 05/07/2009 | WO2008108958A3 Benzimidazole derivatives and methods of use thereof |
| 05/07/2009 | WO2008076278A3 Methods of cancer treatment with igf1r inhibitors |
| 05/07/2009 | WO2008063943A3 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 05/07/2009 | WO2008054200A3 Use of nutritional compositions for preventing disorders |
| 05/07/2009 | WO2008033368A3 Boroproline compound and cytokine combination therapy |
| 05/07/2009 | WO2007041245A3 Biomarkers for multiple sclerosis and methods of use thereof |
| 05/07/2009 | WO2006086330A3 Pharmaceutical compositions |
| 05/07/2009 | US20090118341 Method for treatment of chronic neuropathic pain |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118242 Injectable capsaicin with non-steroidal anti-inflammatory adjunctive agent |
| 05/07/2009 | US20090118221 Method of treating arrhythmias |
| 05/07/2009 | US20090118192 sequentially administering parathyroid hormone and bone resorption inhibitor; bone disorders; osteoporosis |
| 05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090117639 Neural Progenitor Cell Populations |
| 05/07/2009 | US20090117565 Compositions and methods for diagnosis and treating mood disorders |
| 05/07/2009 | US20090117204 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117167 Injectable capsaicin with vasocontrictor adjunctive agent |
| 05/07/2009 | US20090117084 Bacteriophage and prophage proteins in cancer gene therapy |
| 05/07/2009 | US20090117083 Immunomodulatory alkaloids |
| 05/07/2009 | US20090117079 Methods and materials for treating or preventing diseases/disorders mediated by alcohol dehydrogenase |
| 05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
| 05/07/2009 | US20090117072 Treatment of periodontal disease |
| 05/07/2009 | US20090117036 Antibodies against gpr64 and uses thereof |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | DE102007052380A1 Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten Osmolythaltige preparations for use in dry mucous membranes |
| 05/07/2009 | CA2732636A1 Pharmaceutical composition comprising gaboxadol and an inhibitor of pat1 or oat |